CCM
REGN icon

Chilton Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Chilton Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9
Closed -$9.46K – 656
2024
Q3 		$9.46K Sell
9
-11
-55% -$12.2K ﹤0.01% 489
2024
Q2 		$21K Buy
20
+6
+43% +$5.82K ﹤0.01% 445
2024
Q1 		$13.5K Buy
+14
New +$13.3K ﹤0.01% 457
2022
Q3 		– Sell
-10
Closed -$6K – 534
2022
Q2 		$6K Buy
+10
New +$6.5K ﹤0.01% 526
2022
Q1 		– Sell
-209
Closed -$132K – 532
2021
Q4 		$132K Buy
+209
New +$129K 0.01% 252
2016
Q1 		– Sell
-380
Closed -$206K – 171
2015
Q4 		$206K Buy
+380
New +$206K 0.02% 148

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return